Although PIVKA‐II is regarded as a highly specific HCC biomarker, it is disturbed by vitamin K deficiency or antagonist drugs such as warfarin according to its characteristic as a prothrombin induced by vitamin K absence.35 This evidence concerns the gene F2 and hepatocellular carcinoma.